Company news
Abingdon Health Plc (LSE:ABDX) news
Every Abingdon Health Plc press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Abingdon Health plc to Present at the Small Cap Growth Virtual Investor Conference June 4th
June 3, 2026
Presentation at Mello2026
May 29, 2026
US tax credit agreement
May 27, 2026
Earn-out Consideration and Issue of Equity
May 19, 2026
Launch of LVOne Stroke Test by UpFront Diagnostics
May 11, 2026
Update on Partnership with 4TEEN4 Pharmaceuticals
May 6, 2026
Admission to trading on OTCQB in the US
April 21, 2026
EMI Share Option Scheme
April 15, 2026
Trading to commence on the OTCQB in the US
April 14, 2026
£4.8m contracts awarded
March 30, 2026
Half-year Financial Report
March 17, 2026
$2.5m Contract for clinical self-test development
March 12, 2026
Trading on the OTCQB Venture Market in the US
March 10, 2026
Notice of Results
March 5, 2026
Trading Update
January 15, 2026
Appointment of NOMAD & Corporate Broker
January 15, 2026
Exercise of options and total voting rights
December 29, 2025
European patent for AppDx® smartphone reader
December 18, 2025
Result of Annual General Meeting
December 10, 2025
Vesting and Award of Options under LTIP
December 4, 2025
Holding(s) in Company
December 2, 2025
Notice of AGM & Publication of 2025 Annual Report
November 14, 2025
Final Results
November 11, 2025
c.US$2m multiplex diagnostic test contract win
November 10, 2025
Launch of seaweed-based lateral flow housings
November 6, 2025
Result of Meeting and TVR
October 30, 2025
Result of Retail Offer
October 17, 2025
Launch of Retail Offer
October 14, 2025
Result of Placing and Notice of GM
October 14, 2025
Proposed Placing and Retail Offer
October 13, 2025
US CDMO Operations Update
September 1, 2025
Director/PDMR Shareholding
August 14, 2025
Trading update
August 5, 2025
c. US$2.5m companion diagnostic test contract win
July 31, 2025
€2m contract win for companion diagnostic test
June 12, 2025
Update re. strategic partnership with FOFH
June 4, 2025
Avian flu (H5N1) lateral flow test
June 2, 2025
Award of Options under LTIP
May 2, 2025
Half-year Report
March 24, 2025
Directorate Changes
March 24, 2025
Salistick™ to be launched in Germany
March 17, 2025
Funding award to develop test for malaria parasite
January 27, 2025
CS (Lifesciences) Ltd contract win
January 8, 2025
Directorate Change
December 19, 2024
Abingdon Analytical Laboratory opens at Doncaster
December 17, 2024
Contract win: sexually transmitted disease tests
December 17, 2024
Result of AGM
November 19, 2024
AGM Statement
November 19, 2024
Notice of AGM
October 21, 2024
Opening of US commercial office and laboratory
October 15, 2024